Nanjing Hencer Pharmacy Co. Ltd.

A single-center, randomized, open, two-period crossover, single oral trial design was used to compare the differences in absorption extent and absorption rate between the oro-disintegrating tablets (80 mg) of phloroglucinol produced by Nanjing Hengsheng Pharmaceutical Co., Ltd. and the phloroglucinol oral lyophilized tablets (specification: 80 mg) originally developed by Teva Sante and marketed in France under fasting and postprandial administration conditions in healthy Chinese people, and to evaluate the safety of the oro-disintegrating tablets of phloroglucinol produced by Nanjing Hengsheng Pharmaceutical Co., Ltd.

A single-center, randomized, open-label, four-period, completely repeated crossover, single-dose fasting and postprandial administration trial design was used to evaluate the bioequivalence of avatrombopag maleate tablets (specification: 20 mg) produced by Nanjing Hengsheng Pharmaceutical Co., Ltd. and avatrombopag maleate tablets (trade name: Doptelet®/Su Kexin®, specification: 20 mg) certified by AkaRx Inc. in healthy Chinese people when taken orally on an empty stomach and after a meal, to provide evidence for the consistency of clinical efficacy between avatrombopag maleate tablets produced by Nanjing Hengsheng Pharmaceutical Co., Ltd. and avatrombopag maleate tablets certified by AkaRx Inc.

A single-center, randomized, open, dual-cycle, self-crossover, and single-dose administration design was used to evaluate the relationship between nalfuraphine hydrochloride soft capsules (2.5 μg) produced by Zhejiang Kanglaite Pharmaceutical Co., Ltd. and entrusted by Nanjing Hengsheng Pharmaceutical Co., Ltd. Differences in absorption degree and absorption speed and safety of the company's certified nalfuraphine hydrochloride soft capsules (trade name: Remitch®, specification: 2.5μg) among healthy Chinese people.